JLCYX
Price
$69.63
Change
+$0.34 (+0.49%)
Updated
Mar 7 closing price
Net Assets
5.84B
VITSX
Price
$137.99
Change
+$0.72 (+0.52%)
Updated
Mar 7 closing price
Net Assets
1.81T
Ad is loading...

JLCYX vs VITSX

Header iconJLCYX vs VITSX Comparison
Open Charts JLCYX vs VITSXBanner chart's image
JHancock Fundamental Large Cap Core R2
Price$69.63
Change+$0.34 (+0.49%)
VolumeN/A
Net Assets5.84B
Vanguard Total Stock Market Idx I
Price$137.99
Change+$0.72 (+0.52%)
VolumeN/A
Net Assets1.81T
JLCYX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLCYX vs. VITSX commentary
Mar 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCYX is a Buy and VITSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.81T vs. JLCYX (5.84B). VITSX pays higher dividends than JLCYX: VITSX (1.25) vs JLCYX (0.16). JLCYX was incepted earlier than VITSX: JLCYX (13 years) vs VITSX (28 years). JLCYX (1.17) is less costly to investors than VITSX (0.03). JLCYX is a more actively managed with annual turnover of: 19.00 vs. VITSX (2.00). JLCYX has a lower initial minimum investment than VITSX: JLCYX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.84 vs. JLCYX (0.87). VITSX return over 5 years is better than : 88.82 vs. JLCYX (51.21).
JLCYXVITSXJLCYX / VITSX
Total Expense Ratio1.160.033,867%
Annual Report Gross Expense Ratio1.170.033,900%
Fund Existence13 years28 years-
Gain YTD-2.205-2.169102%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.84B1.81T0%
Annual Yield % from dividends0.161.2513%
Returns for 1 year0.8710.848%
Returns for 3 years8.2035.2523%
Returns for 5 years51.2188.8258%
Returns for 10 years70.48177.5140%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMAB24.140.43
+1.81%
Genmab A/S ADS
CSCI2.750.03
+1.04%
COSCIENS Biopharma Inc
ACAD17.56-0.05
-0.28%
ACADIA Pharmaceuticals
CHCT18.49-0.14
-0.75%
Community Healthcare Trust
RMAX8.43-0.19
-2.20%
Re/Max Holdings